ames Atkinson Net Worth
The estimated Net Worth of James G. Atkinson is at least $1.95 Million dollars as of 17 March 2017. Mr. Atkinson owns over 375,000 units of Viveve Medical stock worth over $1,453,699 and over the last 3 years he sold VIVE stock worth over $0. In addition, he makes $495,596 as Chief Business Officer and President at Viveve Medical.
Mr. Atkinson VIVE stock SEC Form 4 insider trading
James has made over 3 trades of the Viveve Medical stock since 2016, according to the Form 4 filled with the SEC. Most recently he bought 375,000 units of VIVE stock worth $1,500,000 on 17 March 2017.
The largest trade he's ever made was buying 375,000 units of Viveve Medical stock on 17 March 2017 worth over $1,500,000. On average, James trades about 82,143 units every 39 days since 2016. As of 17 March 2017 he still owns at least 285,599 units of Viveve Medical stock.
You can see the complete history of Mr. Atkinson stock trades at the bottom of the page.
Sold (or bought if negative) in USD
June 2016
March 2017
-2 000k
-1 500k
-1 000k
-500k
0
wallmine.com
James Atkinson biography
James G. Atkinson is Chief Business Officer and President of Viveve Medical, Inc. He was appointed to serve as the Chief Business Officer and President of the Company and Viveve, Inc., a wholly owned subsidiary of Viveve Medical, Inc., effective as of February 4, 2015. Mr. Atkinson has over 30 years of experience in medical device sales, marketing and business development with both Fortune 50 and start-up medical device companies. Mr. Atkinson was a founding principal at Ulthera, Inc. where he served as Senior Vice President of Sales and Marketing from October 2006 through April 2014. While at Ulthera, he assisted in growing the company from 3 to 165 employees and established a global distribution network that included 42 distributors, covering 52 countries. Mr. Atkinson’s prior experience includes various executive positions, including (i) Vice President of Sales and Marketing for the Cardiac Surgery Division at St. Jude Medical, Inc. from October 2004 to October 2006 where his responsibilities included launching the Biocor® stented tissue valve, recognized as the fastest growing heart valve brand in the industry, (ii) Vice President of Sales for Medtronic Vascular, a $200 million division of Medtronic, Inc., a company whose stock is traded on the New York Stock Exchange (Ticker: MDT), from January 2003 to September 2004 and (iii) co-founder and Vice President of Sales and Business Development for Medical Simulation Corporation. Mr. Atkinson’s career began as a sales representative at Ethicon Endosurgery, a Johnson & Johnson company, where he progressed through positions with increasing responsibility to Regional Manager.
What is the salary of James Atkinson?
As the Chief Business Officer and President of Viveve Medical, the total compensation of James Atkinson at Viveve Medical is $495,596. There are 1 executives at Viveve Medical getting paid more, with Scott Durbin having the highest compensation of $815,128.
Pay (in $)
James Atkinson
Scott Durbin
0
250k
500k
750k
1 000k
wallmine.com
How old is James Atkinson?
James Atkinson is 60, he's been the Chief Business Officer and President of Viveve Medical since 2015. There are no older and 6 younger executives at Viveve Medical.
Age
Scott Durbin
Jon Plexico
Steven Basta
Jim Robbins
Karen Zaderej
Debora Jorn
James Atkinson
0
20
40
60
wallmine.com
Jim Robbins? Age: 54
What's James Atkinson's mailing address?
James's mailing address filed with the SEC is 345 Inverness Dr S #250, Englewood, CO 80112, USA.
Insider trading at Viveve Medical
Over the last 3 years, insiders at Viveve Medical have traded over $444,564 worth of Viveve Medical stock and bought 3,021,700 units worth $13,021,042 . The most active insider traders include Sachs Group Incgoldman Sach..., Daniel Janney, and Capital Management, Llcston.... On average, Viveve Medical executives and independent directors trade stock every 80 days with the average trade being worth of $1,056,725. The most recent stock trade was executed by Sachs Group Incgoldman Sach... on 30 September 2019, trading 92,425 units of VIVE stock currently worth $444,564.
Sold (or bought if negative) in USD
GOLDMAN SACHS GROUP INCGOLDMANSACHS & CO. LLC
Durbin Scott
Scheller Patricia
JANNEY DANIEL
Atkinson James G.
Stonepine Capital Management,LLCSTONEPINE CAPITAL, L.P.Plexico JonMLYNCH TIMOTHY P
-10M
-7.5M
-5M
-2.5M
0
2.5M
wallmine.com
What does Viveve Medical do?
Viveve Medical, Inc. engages in the provision of health products. Its activities include development and distribution of women's health solutions. Its products include non-surgical, non-ablative medical device that remodels collagen and restores vaginal tissue. The company was founded on March 3, 1987 and is headquartered Englewood, CO.
What does Viveve Medical's logo look like?
Viveve Medical, Inc. logo
Complete history of Mr. Atkinson stock trades at Viveve Medical
Date
Company
Insider
Transaction
Shares Price per share Total price Shares after Source
2017-03-17 VIVE James G. Atkinson
CBO and President
Buy 375,000 $4.00 $1,500,000 285,599 ?
2016-06-17 VIVE James G. Atkinson
CBO and President
Buy 100,000 $5.00 $500,000 433,737 ?
2016-06-17 VIVE James G. Atkinson
CBO and President
Buy 100,000 $5.00 $500,000 433,737 ?
Viveve Medical executives and stock owners
Viveve Medical executives and other stock owners filed with the SEC include:
Scott Durbin, Chief Executive Officer, Director
James Atkinson, Chief Business Officer and President
Jim Robbins, Principal Financial Officer
Karen Zaderej, Director
Steven Basta, Director
Jon Plexico, Independent Director
Arlene Morris, Independent Director
Debora Jorn, Director
Sachs Group Incgoldman Sach...,
Daniel Janney, Director
Patricia Scheller, Chief Executive Officer
Lori H Bush, Director
Brigitte Smith, Director
Capital Management, Llcston..., Director
